跳至主要内容
临床试验/CTRI/2025/07/091193
CTRI/2025/07/091193尚未招募不适用

Effect of moderate aerobic exercise with and without resistance on kidney function in chronic kidney disease.

G VENUVENDHAN1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
105
试验地点
1
主要终点
1. Blood urea and creatine

研究概览

简要总结

Aim:

Chronic renal disease is a serious condition that affects the kidney leds to various complications like high blood pressure, anemia, and general weakness and also effects the bones, nerves and heart. Aerobic exercise have various health benefit and prescribed for prevention and management of various diseases like diabetic mellitus, cardiovascular diseases, musculoskeletal problems, age related problems, cancer, etc. but the exercise prescription in the CKD patients are very minimal due the little understanding of the effect of exercise in this patients. Hence the aim of the study is to find effect aerobic exercises in renal functions of chronic renal disease.

Objective:

To find effect aerobic exercise in renal function of chronic kidney disease, functional capacity of CKD patients, fatigability level of CKD patients and Quality of life in CKD patients.

Methodology:

It’s an experimental design with comparative study ( pre and posttest ) in Out Patient Department of physiotherapy - ACS medical college and  Hospitals, Study duration of 24 weeks. sample size of 35 / group ( total 105 for 3 groups) Subjects were Randomly assigned three groups.

Group 1 - Moderate intensity Continues walking and resisted exercise, for minimum 30 min/ day for 5 days a week with the intensity 12 to 14 Borg rating of perceived exertion.

Group 2 - Moderate intensity Continues walking for minimum 30 min / day for 5 days a week with Intensity 12 to 14 on Borg rating of perceived exertion

Group 3 - Conventional where no specific exercise will be prescribed.

Outcome:

Outcome measures are blood urea and creatine, Urine protein, 6 minute walk test, Fatigue Severity Scale and Kidney Disease Quality of Life Short Form

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
30.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • CKD patients with stage 3 and 4 on eGFR
  • Chronic kidney disease with age ranges from 30 to 50 years 3.Both genders
  • Medical clearance for exercise.

排除标准

  • Severe chronic kidney disease – stage 5
  • CKD caused other than diabetes and hypertension
  • Age over and above 50 years
  • Mentally unstable patients
  • Recent myocardial Infraction
  • COPD and Asthma
  • Any neurological conditions that restrict the mobility of the individuals
  • Recent fracture within six months in lower limb and upper limb
  • Severe OA knee, hip or ankle joint
  • Any type of carcinoma
  • Patient those who are physically active (doing moderate exercise).

结局指标

主要结局

1. Blood urea and creatine

时间窗: 24 weeks

2. Urine protein

时间窗: 24 weeks

次要结局

  • 1. 6 minute walk test(2. Fatigue Severity Scale)

研究者

发起方
G VENUVENDHAN
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

G VENUVENDHAN

Dr.MGR Educational and Research Institute

研究点 (1)

Loading locations...

相似试验